MedTech Acquisition Performance
| MTACWDelisted Stock | USD 0.10 0.00 0.00% |
The company secures a Beta (Market Risk) of -5.99, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning MedTech Acquisition are expected to decrease by larger amounts. On the other hand, during market turmoil, MedTech Acquisition is expected to outperform it. MedTech Acquisition right now secures a risk of 0.0%. Please verify MedTech Acquisition jensen alpha and the relationship between the value at risk and relative strength index , to decide if MedTech Acquisition will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days MedTech Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable fundamental indicators, MedTech Acquisition is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 200.9 K | |
| Total Cashflows From Investing Activities | 233.2 M |
MedTech |
MedTech Acquisition Relative Risk vs. Return Landscape
If you would invest 10.00 in MedTech Acquisition on August 25, 2024 and sell it today you would earn a total of 0.00 from holding MedTech Acquisition or generate 0.0% return on investment over 90 days. MedTech Acquisition is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded stocks are less volatile than MedTech, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
MedTech Acquisition Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MedTech Acquisition's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MedTech Acquisition, and traders can use it to determine the average amount a MedTech Acquisition's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MTACW |
Based on monthly moving average MedTech Acquisition is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MedTech Acquisition by adding MedTech Acquisition to a well-diversified portfolio.
MedTech Acquisition Fundamentals Growth
MedTech Stock prices reflect investors' perceptions of the future prospects and financial health of MedTech Acquisition, and MedTech Acquisition fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MedTech Stock performance.
| EBITDA | (8.58 M) | |||
| Cash And Equivalents | 25 K | |||
| Total Debt | 2.37 M | |||
| Debt To Equity | 1.77 % | |||
| Cash Flow From Operations | (2.74 M) | |||
| Total Asset | 20.19 M | |||
| Retained Earnings | (13.27 M) | |||
About MedTech Acquisition Performance
Evaluating MedTech Acquisition's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if MedTech Acquisition has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MedTech Acquisition has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
MedTech Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York. Medtech Acquisition is traded on NASDAQ Exchange in the United States.Things to note about MedTech Acquisition performance evaluation
Checking the ongoing alerts about MedTech Acquisition for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MedTech Acquisition help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MedTech Acquisition is not yet fully synchronised with the market data | |
| MedTech Acquisition has some characteristics of a very speculative penny stock | |
| MedTech Acquisition has a very high chance of going through financial distress in the upcoming years | |
| MedTech Acquisition has accumulated about 25 K in cash with (2.74 M) of positive cash flow from operations. |
- Analyzing MedTech Acquisition's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MedTech Acquisition's stock is overvalued or undervalued compared to its peers.
- Examining MedTech Acquisition's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MedTech Acquisition's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MedTech Acquisition's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MedTech Acquisition's stock. These opinions can provide insight into MedTech Acquisition's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in MedTech Stock
If you are still planning to invest in MedTech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MedTech Acquisition's history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |